Dissolving Microneedle Transdermal Patch Loaded with Nanoliposomes of Enicostemma littorale for the Management of Type II Diabetes
ACS Omega · 01.07.2025 · 10 (25) · 26468-26477
DOI: 10.1021/acsomega.4c11677 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 16.06.2025. Verfasst von Mohammed H Alqarni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 11942, Saudi Arabia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Prince Sattam bin Abdulaziz University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) is the most common form of diabetes and presents a significant global health challenge, characterized by insulin resistance and a relative deficiency in insulin secretion. There is growing interest in exploring crude herbal extracts for diabetes management, particularly Enicostemma littorale (Chota Chirata), an Ayurvedic remedy from the Gentianaceae family. Encapsulating these extracts in nanocarriers has shown promise due to its enhanced bioavailability, targeted delivery, and sustained release. Nanoliposomes (NLs) are extensively studied for delivering E. littorale because of their structural versatility, biocompatibility, and nontoxic nature. To improve transdermal delivery, a dissolving microneedle (DMN) transdermal patch is used. These tiny needles penetrate the skin, bypass the stratum corneum, and enable painless drug delivery. In our study, the NLs were developed using Bangham’s technique of thin film evaporation and were optimized using a design expert (Box-Behnken Design, BBD). The NLs were assessed for vesicle size, polydispersity index (PDI), entrapment efficiency (EE), and zeta potential. The results indicated a vesicle size of 91.09 ± 3.45 nm, a PDI of 0.267 ± 0.06, an EE of 82.45 ± 2.45%, and a zeta potential of −25.19 ± 2.11 mV. In vitro release studies demonstrated a sustained-release pattern for the NL. Ex vivo studies confirmed successful skin permeation with 84.49 ± 1.14% of the formulation permeating through the skin. The MNs were successfully developed and evaluated, with the results indicating potential for further application. In conclusion, the EL-NL-loaded MN exhibited stability and promising in vitro and ex vivo results, suggesting its suitability for continued research and development.
Autor:innen und Institutionen
- Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj 11942, Saudi Arabia.
- R&D Scientist, Aimil Pharmaceuticals, New Delhi 110028, India.
- Department of Pharmaceutical Sciences, Unaizah College of Pharmacy, Qassim University, Unaizah 51911, Saudi Arabia.
- Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj 11942, Saudi Arabia.
ORCID-Profile: Mohd Imran, Ahmed I Foudah
Förderung
- Prince Sattam bin Abdulaziz University
Zitieren
APA
Alqarni, M. H., Imran, M., Foudah, A. I., Hasmi, S., Aodah, A. H., & Alam, A. (2025). Dissolving Microneedle Transdermal Patch Loaded with Nanoliposomes of Enicostemma littorale for the Management of Type II Diabetes. ACS Omega, 10(25), 26468-26477. https://doi.org/10.1021/acsomega.4c11677
Vancouver
Alqarni MH, Imran M, Foudah AI, Hasmi S, Aodah AH, Alam A. Dissolving Microneedle Transdermal Patch Loaded with Nanoliposomes of Enicostemma littorale for the Management of Type II Diabetes. ACS Omega. 2025;10(25):26468-26477. doi:10.1021/acsomega.4c11677
BibTeX
@article{Alqarni2025,
author = {Alqarni, Mohammed H and Imran, Mohd and Foudah, Ahmed I and Hasmi, Sana and Aodah, Alhussain H and Alam, Aftab},
title = {Dissolving Microneedle Transdermal Patch Loaded with Nanoliposomes of Enicostemma littorale for the Management of Type II Diabetes},
journal = {ACS Omega},
year = {2025},
volume = {10},
number = {25},
pages = {26468--26477},
doi = {10.1021/acsomega.4c11677}
}
EUVIMED